Financial Services

Amplify Weight Loss Drug & Treatment ETF(THNR)

ETF

Live Price

Offline

$24.12

-0.59% today

1Y Change

+7.08%

Window

Jun 20, 2025 → Jun 12, 2026

Market Cap: $4.24M
Dividend Yield: 0.0%
50-Day Avg: —
Exchange: AMEX

Coverage: 246 bars · Jun 20, 2025 → Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Amplify Weight Loss Drug & Treatment ETF (THNR) is an ETF with a market cap of $4.24M and listed on AMEX. The ETF last traded around $24.12 and up 7.1% across the available one-year price window (Jun 20, 2025 → Jun 12, 2026). Stock Foundry combines THNR price history, dividend context, analyst forecasts, news, related Financial Services peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

THNR

—

Normalized return

SPY

—

S&P 500

Excess Return

—

Relative to SPY

THNR Max Drawdown

-12.06%

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for THNR and SPY.

Calendar-year return history is still loading or unavailable.

We do not have analyst estimates for THNR yet. Once the upstream feed includes this ticker, the outlook cards and table will light up automatically.

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.

Read the analyst forecasts guide Compare stocks with this setup